SGMO


Company Update (NASDAQ:SGMO): Sangamo Biosciences, Inc. Reports Second Quarter 2015 Financial Results

Sangamo Biosciences, Inc. (NASDAQ:SGMO) reported its second quarter 2015 financial results and accomplishments.

Three Years and $3.2 Million Later, FBI Debunks Cross-Country Insider Trading Scheme

Four men taking part in an illegal insider trading scheme between California, New Jersey, and Florida have been arrested and charged after earning …

Beware Of Sangamo: 20-Year History Of Failures, Misadventures In HIV, And Flawed Approach In B-Thalassemia

Sangamo BioSciences (NASDAQ:SGMO) was founded in 1995 ostensibly to commercialize zinc finger nuclease technology. Twenty years have passed since its founding and there …

Wedbush Reiterates Outperform On Sangamo, Raises PT To $28

In a research note published yesterday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on Sangamo BioSciences (NASDAQ:SGMO) and raised her price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts